title: Transfusion transmission of HCV, a long but successful road map to safety.
abstract: Improved blood banking practices and the development and implementation of increasingly sensitive serological and nucleic acid amplification technology assays for screening donors for HCV over the past few decades have helped minimize the residual risk from transfusion transmitted HCV in the developed world. Furthermore, studies of transfusion transmitted infections and of donors identified as infected by routine screening have provided significant insights into HCV transmission, epidemiology and pathogenesis. However, transfusion transmission of HCV is still a significant route of infection in the developing world. Key preventive mechanisms to ensure safe blood include elimination of paid donors and development of national donor pools comprising volunteer repeat blood donors, combined with implementation of standardized and maximally sensitive screening assays for HCV. There is also a need to develop up-to-date data on HCV disease burden on a global scale, in part, derived from systematic screening of donors for HCV infection. We suggest the creation of blood donor databases and specimen repositories, both at national and international levels, to facilitate epidemiological surveillance and pathogenesis and treatment studies in the future.
authors: Blood Systems Research Institute, San Francisco, CA, USA.
authors: Suganya
authors: S
authors: Selvarajah
authors: Michael P
authors: MP
authors: Busch
mesh_terms: D001771:Blood Banks / Q000592:standards; D001782:Blood Donors / Q000706:statistics & numerical data; D058731:Blood Safety / Q000592:standards*; D001803:Blood Transfusion / Q000592:standards; D003906:Developing Countries; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology / Q000635:transmission* / Q000821:virology; D018937:Hepatitis C Antibodies / Q000097:blood*; D018936:Hepatitis C Antigens / Q000097:blood; D006801:Humans; D008403:Mass Screening; D021141:Nucleic Acid Amplification Techniques; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood*; D065227:Transfusion Reaction; D014481:United States / Q000453:epidemiology; D014766:Viremia
chemical_list: D018937:Hepatitis C Antibodies; D018936:Hepatitis C Antigens; D012367:RNA, Viral